AstraZeneca reported a robust performance for Q2 FY24, showing quarter-over-quarter improvements across key financial metrics.
- Total Revenue from Operations: The revenue from operations rose to ₹408 crore in Q2 FY24, a 5.3% increase from ₹387.5 crore in the previous quarter, Q1 FY24.
- Profit Before Exceptional Item and Tax: The profit before exceptional items and tax grew to ₹51 crore in Q2 FY24, up from ₹42.4 crore in Q1, marking a notable improvement in operational efficiency.
- Profit After Exceptional Item and Tax: AstraZeneca posted a profit after tax of ₹38.4 crore for Q2 FY24, a turnaround from the loss of ₹11.8 crore in Q1 FY24. This marks a significant improvement in the company’s bottom line.
You might also like
Half-Year Performance
For the first half of FY24 (H1 FY24), AstraZeneca’s cumulative revenue from operations stood at ₹795.5 crore. The profit before tax for H1 reached ₹93.4 crore, and the profit after tax totaled ₹26.6 crore, reflecting the company’s strengthened position and recovery trajectory.
This quarter’s results underscore AstraZeneca’s commitment to enhancing operational performance and its focus on profitable growth, with improvements observed both in revenue and profitability metrics.
